Aeovian Pharmaceuticals Revenue, Growth & Competitor Profile

DBA AEONIAN PHARMACEUTICALS
DBA DELOS PHARMACEUTICALS, INC.

Company Profile & Annual Report for Aeovian Pharmaceuticals

Access the complete profile.

Aeovian Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 541711 Research & Development in Biotechnology
Address	2930 Domingo Ave Suite 145 Berkley, CA 94705

Note: Revenues for privately held companies are statistical evaluations.


Aeovian Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Aeovian Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Aeovian Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Aeovian Pharmaceuticals Annual Revenue and Growth Rate

Aeovian Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Aeovian Pharmaceuticals's revenues are gauged from an analysis of company filings.

Aeovian Pharmaceuticals's Income Statement (based on Industry Averages)

Aeovian Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Market Share of Aeovian Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Aeovian Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Aeovian Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
AEOVIAN PHARMACEUTICALS	Berkley, CA	100
SIMPLY FOODS	Berkeley, CA	68
VXBIOSCIENCES	Berkeley, CA	50
CHAMELEON BIOSCIENCES	Berkeley, CA	35
EQUATOR THERAPEUTICS	Richmond, CA	12
BIOPRODUCTION GROUP	Berkeley, CA	8

Future Competition: Aeovian Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Aeovian Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)